PharmaCorp Rx Inc. (TSXV:PCRX)
Canada
· Delayed Price · Currency is CAD 0.450
+0.035 (8.43%)
At close: Apr 28, 2026
PharmaCorp Rx Revenue
PharmaCorp Rx had revenue of 4.80M CAD in the quarter ending September 30, 2025, with 334.82% growth. This brings the company's revenue in the last twelve months to 17.60M, up 1,161.18% year-over-year. In the year 2024, PharmaCorp Rx had annual revenue of 5.79M.
Revenue (ttm)
17.60M
Revenue Growth
+1,161.18%
P/S Ratio
4.27
Revenue / Employee
n/a
Employees
n/a
Market Cap
75.12M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.79M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionPharmaCorp Rx News
- 7 days ago - PharmaCorp Rx Transcript: 2026 Bloom Burton & Co. Healthcare Investor Conference - Transcripts